Compare ICL & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICL | ACHC |
|---|---|---|
| Founded | 1968 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | ICL | ACHC |
|---|---|---|
| Price | $5.18 | $14.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $6.23 | ★ $24.00 |
| AVG Volume (30 Days) | 934.6K | ★ 3.5M |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.29 | ★ 1.18 |
| Revenue | ★ $7,053,000,000.00 | $3,265,548,000.00 |
| Revenue This Year | $5.82 | $6.50 |
| Revenue Next Year | $5.42 | $4.38 |
| P/E Ratio | $17.77 | ★ $12.26 |
| Revenue Growth | 1.77 | ★ 4.58 |
| 52 Week Low | $4.70 | $12.63 |
| 52 Week High | $7.35 | $47.08 |
| Indicator | ICL | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 34.62 |
| Support Level | $4.95 | $13.95 |
| Resistance Level | $5.05 | $14.98 |
| Average True Range (ATR) | 0.09 | 0.72 |
| MACD | 0.04 | 0.21 |
| Stochastic Oscillator | 79.21 | 26.10 |
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.